Clinical Trial: Personalized Probiotic Treatments for Irritable Bowel Syndrome

U.S., Oct. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07872514) titled 'Personalized Probiotic Treatments for Irritable Bowel Syndrome' on Oct. 07.

Brief Summary: Irritable bowel syndrome (IBS) is characterized by stomach pain and altered bowel habits. It affects about 5 million people in Canada. Doctors don't fully understand what causes IBS, so treatments often don't work well. Many patients say certain foods make their symptoms worse. This may be due to how gut bacteria break down food. Some bacteria produce harmful chemicals like histamine and lysophosphatidylcholine (LPC)/lysophosphatidic acid (LPA), which can cause pain and gut problems. These chemicals may affect about 35% of IBS patients. The go...